BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 26005879)

  • 21. The impact of flare on disease costs of patients with systemic lupus erythematosus.
    Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
    Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Flares in pediatric systemic lupus erythematosus.
    Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
    J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low disease activity-irrespective of serologic status at baseline-associated with reduction of corticosteroid dose and number of flares in patients with systemic lupus erythematosus treated with belimumab: A real-life observational study.
    Fanouriakis A; Adamichou C; Koutsoviti S; Panopoulos S; Staveri C; Klagou A; Tsalapaki C; Pantazi L; Konsta S; Mavragani CP; Dimopoulou D; Ntali S; Katsikas G; Boki KA; Vassilopoulos D; Konstantopoulou P; Liossis SN; Elezoglou A; Tektonidou M; Sidiropoulos P; Erden A; Sfikakis PP; Bertsias G; Boumpas DT
    Semin Arthritis Rheum; 2018 Dec; 48(3):467-474. PubMed ID: 29555348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct medical costs and their predictors in South Korean patients with systemic lupus erythematosus.
    Park SY; Joo YB; Shim J; Sung YK; Bae SC
    Rheumatol Int; 2015 Nov; 35(11):1809-15. PubMed ID: 26254885
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of clinical predictors of flare in systemic lupus erythematosus patients: a 24-month prospective cohort study.
    Inês L; Duarte C; Silva RS; Teixeira AS; Fonseca FP; da Silva JA
    Rheumatology (Oxford); 2014 Jan; 53(1):85-9. PubMed ID: 24067885
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elevated BLyS levels in patients with systemic lupus erythematosus: Associated factors and responses to belimumab.
    Roth DA; Thompson A; Tang Y; Hammer AE; Molta CT; Gordon D
    Lupus; 2016 Apr; 25(4):346-54. PubMed ID: 26385220
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical characteristics and outcome of southern Chinese males with systemic lupus erythematosus.
    Mok CC; Lau CS; Chan TM; Wong RW
    Lupus; 1999; 8(3):188-96. PubMed ID: 10342711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Early Lupus Project - A multicentre Italian study on systemic lupus erythematosus of recent onset.
    Sebastiani GD; Prevete I; Piga M; Iuliano A; Bettio S; Bortoluzzi A; Coladonato L; Tani C; Spinelli FR; Fineschi I; Mathieu A
    Lupus; 2015 Oct; 24(12):1276-82. PubMed ID: 25979916
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Swiss Systemic lupus erythematosus Cohort Study (SSCS) - cross-sectional analysis of clinical characteristics and treatments across different medical disciplines in Switzerland.
    Ribi C; Trendelenburg M; Gayet-Ageron A; Cohen C; Dayer E; Eisenberger U; Hauser T; Hunziker T; Leimgruber A; Lindner G; Koenig K; Otto P; Spertini F; Stoll T; Von Kempis J; Chizzolini C;
    Swiss Med Wkly; 2014; 144():w13990. PubMed ID: 25115978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Disease control and safety of belimumab plus standard therapy over 7 years in patients with systemic lupus erythematosus.
    Ginzler EM; Wallace DJ; Merrill JT; Furie RA; Stohl W; Chatham WW; Weinstein A; McKay JD; McCune WJ; Zhong ZJ; Freimuth WW; Petri MA;
    J Rheumatol; 2014 Feb; 41(2):300-9. PubMed ID: 24187095
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum tenascin-C discriminates patients with active SLE from inactive patients and healthy controls and predicts the need to escalate immunosuppressive therapy: a cohort study.
    Závada J; Uher M; Svobodová R; Olejárová M; Hušáková M; Ciferská H; Hulejová H; Tomčík M; Šenolt L; Vencovský J
    Arthritis Res Ther; 2015 Nov; 17():341. PubMed ID: 26608564
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycophenolate mofetil is effective in reducing disease flares in systemic lupus erythematosus patients: a retrospective study.
    Nannini C; Crowson CS; Matteson EL; Moder KG
    Lupus; 2009 Apr; 18(5):394-9. PubMed ID: 19318390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical features and long-term outcomes of systemic lupus erythematosus: comparative data of childhood, adult and late-onset disease in a national register.
    Sousa S; Gonçalves MJ; Inês LS; Eugénio G; Jesus D; Fernandes S; Terroso G; Romão VC; Cerqueira M; Raposo A; Couto M; Nero P; Sequeira G; Nóvoa T; Melo Gomes JA; da Silva JC; Costa L; Macieira C; Silva C; Silva JA; Canhão H; Santos MJ
    Rheumatol Int; 2016 Jul; 36(7):955-60. PubMed ID: 26979603
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Economic burden of systemic lupus erythematosus flares and comorbidities in a commercially insured population in the United States.
    Narayanan S; Wilson K; Ogelsby A; Juneau P; Durden E
    J Occup Environ Med; 2013 Nov; 55(11):1262-70. PubMed ID: 24202242
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic strategies in severe neuropsychiatric systemic lupus erythematosus: experience from a tertiary referral centre.
    Bortoluzzi A; Padovan M; Farina I; Galuppi E; De Leonardis F; Govoni M
    Reumatismo; 2012 Dec; 64(6):350-9. PubMed ID: 23285478
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment patterns and medical cost of systemic lupus erythematosus patients in Japan: a retrospective claims database study.
    Miyazaki C; Sruamsiri R; Mahlich J; Jung W
    J Med Econ; 2020 Jul; 23(7):786-799. PubMed ID: 32149541
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinico-biological issues of systemic lupus erythematosus patients].
    Belibou IC; Ancuţa C; Miu S; Ancuţa E; Păstrăguş C; Chirieac R
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):83-9. PubMed ID: 23077877
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A structured literature review of the direct costs of adult systemic lupus erythematosus in the US.
    Slawsky KA; Fernandes AW; Fusfeld L; Manzi S; Goss TF
    Arthritis Care Res (Hoboken); 2011 Sep; 63(9):1224-32. PubMed ID: 21584945
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Retrospective Analysis of Disease Severity, Health Care Resource Utilization, and Costs Among Patients Initiating Belimumab for the Treatment of Systemic Lupus Erythematosus.
    Lokhandwala T; Coutinho AD; Bell CF
    Clin Ther; 2021 Aug; 43(8):1320-1335. PubMed ID: 34243966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
    Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
    Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.